Physician profile
Mark S Maehrer
NPI 1811941636
$1,261.39
in general payments reported to CMS, 2019-2025
19 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $65.94 · 2021: $84.58 · 2022: $216 · 2023: $224 · 2024: $300 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630 · Travel and Lodging: $12.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.90 |
| Travel and Lodging | $12.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $220.47 | 2019-2023 | Prevena, Activ.A.C. Ion Progress, V.A.C. Veraflo Cleanse Choice |
| Stryker Corporation | $151.70 | 2019-2024 | Phalinx |
| Ucb, INC. | $119.19 | 2024 | Cimzia, Bimzelx |
| Organogenesis INC. | $114.92 | 2021-2023 | Puraply |
| Alexion Pharmaceuticals, INC. | $96.60 | 2022 | |
| Paratek Pharmaceuticals, INC. | $93.70 | 2025 | Nuzyra |
| Radius Health, INC. | $76.87 | 2020-2024 | Tymlos |
| Ibsa Pharma INC. | $72.17 | 2023-2025 | Tirosint, Licart, Flector |
| Reprise Biomedical, INC. | $45.65 | 2023 | Miro3d |
| Abbvie INC. | $43.85 | 2019-2022 | |
| Amgen INC. | $41.39 | 2019-2024 | Krystexxa |
| Aurinia Pharma U.S., INC. | $32.91 | 2021 | |
| Smith+Nephew, INC. | $32.60 | 2019 | |
| Janssen Biotech, INC. | $32.08 | 2024 | Tremfya |
| Averitas Pharma INC. | $24.07 | 2024 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $23.18 | 2024 | Orthovisc, Monovisc |
| Grt US Holding, INC. | $20.26 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $12.52 | 2023 | |
| Orthofix Medical, INC. | $7.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Maehrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.